Found 8 matching trials
Evaluation of Efficacy of Dellegra in Exposure Unit PHASE4 Primary Objective:
To collect and analyze clinical data of Allergic Rhinit...
Show More Location
Investigational Site Number 392-001
Learn More & Join Trial
Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis. PHASE3 The loratadine-pseudoephedrine combination has proven to be more effective ...
Show More Location
Lal Clínica Pesquisa E Desenvolvimento Ltda
Learn More & Join Trial
A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge PHASE2 An H3 receptor antagonist should reduce the congestion associated with alle...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above PHASE4 This is a single group, Phase IV clinical trial to assess the safety and ef...
Show More Location
Misha ENT Hospital
Learn More & Join Trial
Fexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic Rhinitis PHASE3 Primary Objective:
\- To evaluate the efficacy on the nasal congestion of ...
Show More Location
Investigational Site Number 392002
Learn More & Join Trial
Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr.Reddy's Under Fed Conditions PHASE1 The purpose of this study is to
1. Compare and evaluate the single dose, c...
Show More Location
Veeda Clinical Research Pvt. Ltd.,
Learn More & Join Trial
Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr. Reddy's and Allegra D 24 Hour ER Tablets Under Fasting Conditions PHASE1 The purpose of this study is to
1. Compare and evaluate the single dose, c...
Show More Location
Veeda Clinical Research Pvt. Ltd.,
Learn More & Join Trial
The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis PHASE2 PF-03654764 should reduce the symptoms of allergic rhinitis. In this study ...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial